International network of researchers aiming to accelerate vaccine development for TB, leishmaniasis, melioidosis &leprosy. Led by @UniofOxford - open to all
Preparing to rollout next-generation #tuberculosis vaccines takes careful planning to shape policies, inform implementation strategies and decide who to prioritise. Two South African experts dive into the logistics of ensuring these new vaccines will have the maximum possible impact: https://t.co/poF9GIj2iH
CIFAR’s renowned Global Scholars program is designed for early-career researchers worldwide.
Develop and lead highly interdisciplinary research, expand your network and gain valuable leadership training.
Details: https://t.co/INUp1JfGdw
Tuberculosis in 2026 demands moving past outdated diagnostic latencies: rapid molecular platforms, targeted short-course regimens, and closing global care gaps.
Join our scientific session:
🔬 Advances in TB: Diagnosis and Care
📅 Tuesday, Oct 20 | 2:45 PM – 3:45 PM MST
📍 Phoenix Convention Center, North Building 124 B
Excited to exchange frontline clinical protocols!
#DrSarangPatil #CHEST2026 #Tuberculosis #ChestInfections
Vaccination may increasingly support health across the life course—from pregnancy and childhood to older age.
This SciPod audio feature explores what that shift could mean for vaccine science and access.
🎧: https://t.co/TnWkv9zewR
Deadline extended!
Fully Funded PGD Studentship
Applications are still open for a unique research training program offered by @KEMRI_Wellcome and @PU_Kilifi
See additional projects!
Apply now: https://t.co/wPbSAzIDas
Deadline: 25 October 2026
Humans homozygous for rare or common hypomorphic IL23R variants are prone to #tuberculosis. From Olguín Calderón, Kilpatrick, Conil, Philippot, @casanova_lab, Boisson-Dupuis et al.: https://t.co/t0brcIVWLT
📘 From our #Cytokines collection: https://t.co/Yy4C2eb6E3
#Cytokines2026
19 October 1943 – Streptomycin, the first antibiotic remedy for tuberculosis, is isolated by researchers at Rutgers University.
https://t.co/MEDHglk58e
📢 The World Health Organization (WHO) has launched the TB in pregnancy and lactation research toolkit, a new online resource designed to support the earlier and optimal inclusion of pregnant and lactating women in TB research.
Read more about it here:
https://t.co/dRuJedhLTS
Defeating pulmonary tuberculosis in 2026 requires moving beyond legacy diagnostic delays and standardizing rapid molecular susceptibility testing.
Join our scientific session:
🔬 Advances in TB: Diagnosis and Care
📅 Tuesday, Oct 20 | 2:45 PM – 3:45 PM MST
📍 North Building 124 B
Excited to exchange frontline clinical strategies with global colleagues!
#DrSarangPatil #CHEST2026 #Tuberculosis #ChestInfections
October 10 was World Mental Health Day.
Falling ill with tuberculosis (TB) and all the disruption and stress that goes along with it can take a toll on someone’s mental health, and mental health problems can in turn make someone more vulnerable to TB.
#endtb
New Research: Editorial: Factors for the progression from latent tuberculosis infection to tuberculosis disease, volume II www.frontiersin.org/articles/10.3389/fcimb.2026.2007586 #FrontiersIn#CellularInfectionMicrobiology
We would like to inform our members of the following exciting upcoming event!
👉 British Society for Immunology Congress 2026
📅 Dates: Monday, 30 Nov to Thursday, 3 Dec 2026📍 Location:Glasgow, UK
Register here: https://t.co/xgAMOO2qqR
New Research: Nutrition, thyroid function, and tuberculosis: exploring the endocrine–immune axis www.frontiersin.org/articles/10.3389/ftubr.2026.1945832 #FrontiersIn#Tuberculosis
New Research: Spondylodiscitis in a tuberculosis-endemic setting in Somalia: epidemiological, clinical, radiological, and outcome findings from a retrospective study www.frontiersin.org/articles/10.3389/ftubr.2026.1971442 #FrontiersIn#Tuberculosis